Brainsway Stock Total Debt

BRSYF Stock  USD 8.53  0.00  0.00%   
BrainsWay fundamentals help investors to digest information that contributes to BrainsWay's financial success or failures. It also enables traders to predict the movement of BrainsWay Pink Sheet. The fundamental analysis module provides a way to measure BrainsWay's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BrainsWay pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

BrainsWay Company Total Debt Analysis

BrainsWay's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Total Debt

 = 

Bonds

+

Notes

More About Total Debt | All Equity Analysis

Current BrainsWay Total Debt

    
  754 K  
Most of BrainsWay's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BrainsWay is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Competition

Based on the latest financial disclosure, BrainsWay has a Total Debt of 754 K. This is 99.97% lower than that of the Healthcare sector and 99.96% lower than that of the Medical Devices industry. The total debt for all United States stocks is 99.99% higher than that of the company.

BrainsWay Total Debt Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BrainsWay's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of BrainsWay could also be used in its relative valuation, which is a method of valuing BrainsWay by comparing valuation metrics of similar companies.
BrainsWay is currently under evaluation in total debt category among its peers.

BrainsWay Fundamentals

About BrainsWay Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze BrainsWay's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BrainsWay using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BrainsWay based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in BrainsWay Pink Sheet

When determining whether BrainsWay offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BrainsWay's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainsway Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainsway Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BrainsWay. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
For more detail on how to invest in BrainsWay Pink Sheet please use our How to Invest in BrainsWay guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Please note, there is a significant difference between BrainsWay's value and its price as these two are different measures arrived at by different means. Investors typically determine if BrainsWay is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BrainsWay's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.